Market news for the last while has seemed to be almost completely focused on the trade war between the U.S. and China – to the point that investors seem to be getting what some might call “trade fatigue” – which could be a point where even if or when a deal is made, the broad […]
Read MoreGalmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. The company is develops Aramchol, an oral therapy, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. […]
Read MoreHow Investors Reacted Market participants viewed Monday’s filing delay as a sign that the company may have erred in buying Level 3, which many bulls initially argued set up CenturyLink for more growth than other peers in the wireline industry. CTL stock responded with a 6.3% decline on Monday to $12.15 per share. That loss […]
Read More